GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

January 28, 2005

Primary Completion Date

October 1, 2006

Study Completion Date

October 25, 2006

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

fluticasone propionate/salmeterol combination DISKUS

Trial Locations (5)

187-0002

GSK Investigational Site, Kodaira

612-0026

GSK Investigational Site, Kyoto

596-8501

GSK Investigational Site, Osaka

164-0012

GSK Investigational Site, Tokyo

Unknown

GSK Investigational Site

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00269087 - GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) | Biotech Hunter | Biotech Hunter